News from aperion biologics, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 23, 2015, 06:00 ET Aperion Biologics, Inc. Announces the Filing of an Offering Statement to Raise $20 Million in a Public Offering under Regulation A -- WR Hambrecht + Co to Act as Sole Underwriter

For immediate release: Today Aperion Biologics, Inc. announces that it has filed an Offering Statement on Form 1-A with the Securities and Exchange...

Apr 22, 2014, 05:46 ET Aperion Biologics, Inc. consigue la Marca CE para el dispositivo de sustitución Z-Lig ACL

Aperion Biologics, Inc. ha recibido la aprobación de la Marca CE para su principal producto, el dispositivo Z-Lig™ ACLR, que será usado por los...

Apr 22, 2014, 05:43 ET Aperion Biologics, Inc. erhält CE-Kennzeichnung für das Z-Lig ACL-Ersatzprodukt

Aperion Biologics, Inc. hat für sein Hauptprodukt, das Z-Lig™ ACLR-Produkt, die CE-Kennzeichnung erhalten und es kann jetzt von Chirurgen in der...

Apr 22, 2014, 05:41 ET Aperion Biologics, Inc. obtient le marquage « CE » pour son dispositif Z-Lig de remplacement du LCA

Aperion Biologics, Inc. a obtenu l'autorisation de marquage « CE » pour son produit phare, le dispositif ACLR Z-Lig™, qui sera utilisé par les...

Apr 22, 2014, 03:00 ET Aperion Biologics, Inc. Granted CE Mark for Z-Lig ACL Replacement Device

Aperion Biologics, Inc. was granted the CE Mark approval for its lead product, the Z-Lig™ ACLR device, to be used by surgeons in the European Union...

Mar 11, 2014, 06:30 ET France Dixon Helfer and Mike Ward Appointed to the Board of Directors of Aperion Biologics, Inc.

Aperion Biologics, Inc., a clinical-stage regenerative medical device company, announced that France Dixon Helfer and Mike Ward were appointed to the ...

Mar 28, 2012, 06:30 ET Aperion Biologics Completes Enrollment in Z-Lig™ Anterior Cruciate Ligament Reconstruction Medical Device Performance Trial

Aperion Biologics, Inc. announced that it has completed patient enrollment and implantation in the Company's clinical trial of its Z-Lig™ Anterior...

Sep 16, 2011, 06:30 ET Aperion Biologics Invited to Present at the UBS Global Life Sciences Conference

Aperion Biologics, Inc. announced today that the company will be presenting at the 2011 UBS Global Life Sciences Conference at the Grand Hyatt New...

Sep 14, 2011, 06:30 ET Aperion Biologics Reaches Midpoint of Enrollment in Z-Lig™ Anterior Cruciate Ligament Reconstruction Medical Device Performance Trial

Aperion Biologics, Inc. announced that it has reached the midpoint of patient enrollment and implantation in the Company's clinical trial of its...

Feb 11, 2011, 03:44 ET Aperion Biologics Initiates Clinical Trial of Z-Lig™ Device for Anterior Cruciate Ligament Reconstruction

Aperion Biologics, Inc. announced the enrollment and implantation of the first patients in the Company's clinical trial of its Z-Lig™ Anterior...